Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

KVUE - Kenvue Inc.


Close
21.625
0.035   0.162%

Share volume: 212,836
Last Updated: Fri 27 Dec 2024 08:30:41 PM CET
Toilet Preparation Manufacturing: 2.47%

PREVIOUS CLOSE
CHG
CHG%

$21.59
0.04
0.16%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
80%
Profitability 88%
Dept financing 45%
Liquidity 44%
Performance 90%
Company vs Stock growth
vs
Performance
5 Days
0.60%
1 Month
-9.99%
3 Months
-6.62%
6 Months
17.92%
1 Year
0.79%
2 Year
-19.26%
Key data
Stock price
$21.62
P/E Ratio 
33.42
DAY RANGE
$21.57 - $21.80
EPS 
$0.65
52 WEEK RANGE
$17.94 - $24.46
52 WEEK CHANGE
$0.88
MARKET CAP 
42.038 B
YIELD 
3.61%
SHARES OUTSTANDING 
1.915 B
DIVIDEND
$0.205
EX-DIVIDEND DATE
08/14/2024
NEXT EARNINGS DATE
10/31/2024
BETA 
0.68
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$12,843,836
AVERAGE 30 VOLUME 
$12,544,317
Company detail
CEO: Thibaut Mongon
Region: US
Website: www.jnj.com/kenvue/
Employees: 0
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Toilet Preparation Manufacturing
Sector: Manufacturing

We are the world’s largest pure-play consumer health company by revenue with $15.0 billion in net sales in 2022. We combine the power of science with meaningful human insights and digital-first capabilities, which we believe empowers approximately 1.2 billion people to live healthier lives every day. Prior to the completion of this offering, we are a wholly owned subsidiary of Johnson & Johnson. Our principal executive offices are located at 199 Grandview Road, Skillman, NJ.

Recent news